Houma Doctor Pleads Guilty to Distributing Misbranded Versions of Injectable Contraceptives to Patients

NEW ORLEANS – U.S. Attorney Duane A. Evans announced today that MICHELLE ANDRE, a resident and doctor in Houma pled guilty to a one-count bill of information on February 29, 2024 before United States District Judge Barry Ashe, to distributing misbranded drugs in violation of 21 U.S.C. § 331. 

According to court documents, from April 2018 through March 2023, ANDRE introduced misbranded drugs, including Depo-Provera, into interstate commerce. The Depo-Provera lacked adequate directions for use in its labeling. 

ANDRE faces a maximum term of up to one year imprisonment and one year of supervised release. Sentencing before Judge Ashe is scheduled for June 6, 2024.

“Selling illegal prescription drugs, particularly sterile injectable products, in the U.S. marketplace puts all consumers’ health at risk,” said Justin Fielder, Special Agent in Charge, FDA Office of Criminal Investigations Miami Field Office. “We will continue to pursue and bring to justice those who jeopardize the public’s health.”

U.S. Attorney Evans praised the work of the Food and Drug Administration. Assistant United States Attorneys Rachal Cassagne of the Narcotics Unit and Paul Hubbell of the General Crimes Unit are in charge of the prosecution.